Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:54 pm Purchase | 2024-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | ARMISTICE CAPITAL LLC | 934,312 9.990% | 934,312 (New Position) | Filing History |
| 2025-01-28 4:44 pm Purchase | 2025-01-27 | 13D | Quoin Pharmaceuticals, Ltd. QNRX | Michael Myers | 939,230 4.900% | 316,657 (+50.86%) | Filing History |
| 2025-01-28 4:43 pm Purchase | 2025-01-27 | 13D | Quoin Pharmaceuticals, Ltd. QNRX | Denise Carter | 939,238 4.900% | 316,825 (+50.90%) | Filing History |
| 2025-01-02 5:20 pm Purchase | 2024-12-23 | 13D | Quoin Pharmaceuticals, Ltd. QNRX | Denise Carter | 622,413 6.900% | 622,413 (New Position) | Filing History |
| 2025-01-02 5:20 pm Purchase | 2024-12-23 | 13D | Quoin Pharmaceuticals, Ltd. QNRX | Michael Myers | 622,573 6.900% | 622,573 (New Position) | Filing History |
| 2024-11-14 7:23 pm Purchase | 2024-09-30 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Lind Global Fund II LP | 62,500 1.200% | 62,500 (New Position) | Filing History |
| 2024-02-13 8:11 pm Sale | 2023-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Lind Global Fund II LP | 62,500 6.000% | -20,000 (-24.24%) | Filing History |
| 2023-03-03 4:18 pm Purchase | 2023-02-24 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Lind Global Fund II LP | 82,500 9.900% | 82,500 (New Position) | Filing History |
| 2023-02-14 2:40 pm Purchase | 2022-12-30 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | GOLDMAN SACHS GROUP INC GS | 4 0.000% | 4 (New Position) | Filing History |
| 2023-02-14 11:25 am Sale | 2022-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | CVI Investments, Inc. | 106,061,462 4.900% | -18,938,538 (-15.15%) | Filing History |
| 2022-08-12 10:01 am Purchase | 2022-08-05 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | CVI Investments, Inc. | 125,000,000 8.200% | 125,000,000 (New Position) | Filing History |
| 2022-03-10 3:26 pm Purchase | 2022-02-28 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | GOLDMAN SACHS GROUP INC GS | 9,670 17.400% | 4,531 (+88.16%) | Filing History |
| 2022-02-14 3:06 pm Purchase | 2021-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Altium Capital Management LLC | 28,508 4.990% | 20,252 (+245.30%) | Filing History |
| 2022-02-10 4:32 pm Purchase | 2021-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | GOLDMAN SACHS GROUP INC GS | 5,139 9.200% | 5,139 (New Position) | Filing History |
| 2021-11-12 2:20 pm Purchase | 2021-10-29 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Altium Capital Management LLC | 8,256 9.990% | 8,256 (New Position) | Filing History |
| 2021-02-16 09:42 am Sale | 2020-12-31 | 13G | CELLECT BIOTECHNOLOGY LTD SPON APOP | CVI Investments, Inc. | 0 0.000% | -30,500,000 (Position Closed) | Filing History |
| 2021-01-13 09:03 am Sale | 2020-12-31 | 13G | CELLECT BIOTECHNOLOGY LTD SPON APOP | Empery Asset Management LP | 185,200 0.050% | -32,114,800 (-99.43%) | Filing History |
| 2020-04-22 3:14 pm Sale | 2019-05-31 | 13D | CELLECT BIOTECHNOLOGY LTD SPON APOP | Yarkoni Shai | 21,197,983 6.200% | -15,202,859 (-41.77%) | Filing History |